article thumbnail

MyMD Pharmaceuticals Announces Fourth Quarter 2021 Initiation of Phase 2 Clinical Trial of MYMD-1 for Extending Healthy Lifespan

Cannabis Law Report

(Nasdaq: MYMD) (“MyMD” or “the Company”), a clinical stage pharmaceutical company committed to extending healthy lifespan, today announced that it intends to initiate dosing for a Phase 2 trial of MYMD-1’s function in delaying aging early in the fourth quarter of 2021. Media: media@mymd.com. in the blood. 646) 421-9523.

article thumbnail

GW Pharmaceuticals Pre-Announces Preliminary Unaudited Fourth Quarter and Full-Year 2019 Net Product Sales

Cannabis Law Report

12, 2020 (GLOBE NEWSWIRE) — GW Pharmaceuticals plc (Nasdaq: GWPH), the world leader in the science, development, and commercialization of cannabinoid prescription medicines, today reported preliminary, unaudited net product sales for the fourth quarter and full-year 2019 and key priorities for 2020. Media Enquiries: Sam Brown Inc.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Cannabis 3.0 Accelerates Access to Consumer and Medical Research

Cannabis Law Report

Moreover over half of current cannabis users (52%) used apps on their mobile phone/tablet yesterday, with 66% reporting mobile app usage in the past week, and 74% reporting use in the past month, according to Vividata’s Spring Cannabis Consumer Study 2019. Virtual Clinical Trials transcend geographic, mobility and economic barriers.

article thumbnail

Cannabis laws in Japan: Is weed legal?

The Cannigma

This was notoriously reflected in the 2020 arrest of a Japanese man and woman for speaking positively about using cannabis in social media posts. In 2019, Japan approved clinical trials for Epidiolox — a cannabis derived medicine used to treat severe forms of childhood epilepsy such as Dravet and Lennox-Gastaut syndromes.

Law 137
article thumbnail

Today’s Answer of the Day

TheAnswerPage

According to reports in the media and statements on various CBD websites, CBD has anti-depressant effects. Do the results of randomized clinical trials support those claims? April 2019 systematic review on the role of cannabidiol in psychiatry found that CBD has no efficacy in depression and bipolar disorders.

article thumbnail

Perez Hilton and Centuria Foods Launch New CBD Gummies, My True 10

Cannabis Law Report

–(BUSINESS WIRE)–Celebrity blogger and media personality Perez Hilton and leading hemp-based CBD researchers have forged a business partnership in support of My True 10 , a CBD Gummies line available at mytrue10.com Perez Hilton’s Personal Wellness Journey Encourages & Supports Others to Live Well. CARSON CITY, Nev.–(BUSINESS

Food 105
article thumbnail

‘Too costly, not enough evidence it works’, says UK in blow to cannabis campaigners

Cannabis Law Report

In November 2018, the legal status of cannabis was changed to allow specialist clinicians to legally prescribe cannabis-derived medicinal products to patients with an exceptional clinical need, following a high-profile media campaign. The final guideline is expected to be published in November 2019.